[Clinical experience with a new synthetic product: diethanolamine pyruvate o-ethoxybenzoil-hydrazone associated with vitamins B1, B6 and B12 and with di-isopropylammonium dichloroethanoate in the treatment of rheumatic and neuritic pain syndromes].
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D001168:Arthritis / Q000188:drug therapy*; D004357:Drug Synergism; D005260:Female; D006801:Humans; D008297:Male; D011736:Pyridoxine / Q000627:therapeutic use*; D011773:Pyruvates / Q000627:therapeutic use*; D000644:Quaternary Ammonium Compounds / Q000627:therapeutic use*; D012216:Rheumatic Diseases / Q000188:drug therapy*; D012585:Sciatica / Q000188:drug therapy*; D013831:Thiamine / Q000627:therapeutic use*; D014805:Vitamin B 12 / Q000627:therapeutic use*
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D011773:Pyruvates; D000644:Quaternary Ammonium Compounds; D011736:Pyridoxine; D014805:Vitamin B 12; D013831:Thiamine
Sperimentazione clinica di un nuovo prodotto di sintesi: l'o-etossibenzoil-idrazone del piruvato di dietanolamina associato alle vitamine B1, B6 e B12 ed al dicloroetanoato di diisopropilammonio nel trattamento delle sindromi dolorose reumatiche e nevritiche.